0000882104-20-000197.txt : 20201204
0000882104-20-000197.hdr.sgml : 20201204
20201204211730
ACCESSION NUMBER: 0000882104-20-000197
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201202
FILED AS OF DATE: 20201204
DATE AS OF CHANGE: 20201204
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Stone Christopher Lewis
CENTRAL INDEX KEY: 0001453373
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19756
FILM NUMBER: 201371197
MAIL ADDRESS:
STREET 1: 932 SOUTHWOOD BLVD.
CITY: INCLINE VILLAGE
STATE: NV
ZIP: 89451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PDL BIOPHARMA, INC.
CENTRAL INDEX KEY: 0000882104
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 943023969
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 932 SOUTHWOOD BLVD
CITY: INCLINE VILLAGE
STATE: NV
ZIP: 89451
BUSINESS PHONE: 775-832-8500
MAIL ADDRESS:
STREET 1: 932 SOUTHWOOD BLVD
CITY: INCLINE VILLAGE
STATE: NV
ZIP: 89451
FORMER COMPANY:
FORMER CONFORMED NAME: PROTEIN DESIGN LABS INC/DE
DATE OF NAME CHANGE: 19930328
4
1
wf-form4_160713463756912.xml
FORM 4
X0306
4
2020-12-02
0
0000882104
PDL BIOPHARMA, INC.
PDLI
0001453373
Stone Christopher Lewis
C/O PDL BIOPHARMA, INC.
932 SOUTHWOOD BLVD.
INCLINE VILLAGE
NV
89451
0
1
0
0
VP, Gen. Counsel & Secretary
Common stock
2020-12-02
4
D
0
11544
0
D
605559
D
Disposition of a portion of a restricted stock award due to performance criteria not being achieved under equity incentive plans.
/s/ Nathan Kryszak, Attorney-in-Fact for Christopher Stone
2020-12-04